- Home
- SBSI vs FTRE Comparison
SBSI vs FTRE Comparison
Compare SBSI & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBSI
- FTRE
- Stock Information
- Founded
- SBSI 1960
- FTRE 1996
- Country
- SBSI United States
- FTRE United States
- Employees
- SBSI N/A
- FTRE N/A
- Industry
- SBSI Major Banks
- FTRE Medical Specialities
- Sector
- SBSI Finance
- FTRE Health Care
- Exchange
- SBSI Nasdaq
- FTRE Nasdaq
- Market Cap
- SBSI 920.2M
- FTRE 864.4M
- IPO Year
- SBSI N/A
- FTRE N/A
- Fundamental
- Price
- SBSI $29.84
- FTRE $13.02
- Analyst Decision
- SBSI Hold
- FTRE Hold
- Analyst Count
- SBSI 3
- FTRE 8
- Target Price
- SBSI $33.50
- FTRE $11.64
- AVG Volume (30 Days)
- SBSI 166.4K
- FTRE 1.5M
- Earning Date
- SBSI 10-24-2025
- FTRE 11-05-2025
- Dividend Yield
- SBSI 4.90%
- FTRE N/A
- EPS Growth
- SBSI N/A
- FTRE N/A
- EPS
- SBSI 2.30
- FTRE N/A
- Revenue
- SBSI $236,346,000.00
- FTRE $2,759,900,000.00
- Revenue This Year
- SBSI $11.21
- FTRE $0.47
- Revenue Next Year
- SBSI $5.52
- FTRE N/A
- P/E Ratio
- SBSI $12.78
- FTRE N/A
- Revenue Growth
- SBSI N/A
- FTRE 1.88
- 52 Week Low
- SBSI $25.85
- FTRE $3.97
- 52 Week High
- SBSI $36.04
- FTRE $25.05
- Technical
- Relative Strength Index (RSI)
- SBSI 63.07
- FTRE 66.15
- Support Level
- SBSI $28.23
- FTRE $9.87
- Resistance Level
- SBSI $29.95
- FTRE $13.37
- Average True Range (ATR)
- SBSI 0.60
- FTRE 0.94
- MACD
- SBSI 0.14
- FTRE 0.21
- Stochastic Oscillator
- SBSI 94.24
- FTRE 89.92
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About FTRE Fortrea Holdings Inc.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.